There is growing consensus MR guided biopsies will become the gold standard. This article in the March issue of Urology Times identifies 4 categories of men who may benefit.
A. Men who have had previous negative biopsies, but rising PSA.
B. Men on or considering active surveillance.
C. Men going in for their first biopsy and if they have to have a biopsy they demand the very best.
D. Men who have had focal therapy.
